Cover Image

Applications of 18(F) FDG PET/CT in oncology

The escalating costs of conventional diagnostic technology in oncology have yet to obviate futile surgery intervention and the spiralling treatment cost. The evolution in engineering technology which looks at the correlation of the anatomy and the function of tumours i.e. Positron Emission Tomograph...

Full description

Saved in:
Bibliographic Details
Main Authors: Ahmad Saad, Fathinul Fikri, Nordin, Abdul Jalil, Cheah, Yoke Kqueen, Ahmad Saad, F. N.
Format: Article
Language:English
Published: Universiti Putra Malaysia Press 2015
Online Access:http://psasir.upm.edu.my/id/eprint/40625/1/Applications%20of%2018%28F%29%20FDG%20PETCT%20in%20oncology.pdf
http://psasir.upm.edu.my/id/eprint/40625/
http://www.pertanika.upm.edu.my/Pertanika%20PAPERS/JST%20Vol.%2023%20%281%29%20Jan.%202015/%281%29%20JST-0431-2012%20Revised.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
id my.upm.eprints.40625
record_format eprints
spelling my.upm.eprints.406252015-11-27T01:27:42Z http://psasir.upm.edu.my/id/eprint/40625/ Applications of 18(F) FDG PET/CT in oncology Ahmad Saad, Fathinul Fikri Nordin, Abdul Jalil Cheah, Yoke Kqueen Ahmad Saad, F. N. The escalating costs of conventional diagnostic technology in oncology have yet to obviate futile surgery intervention and the spiralling treatment cost. The evolution in engineering technology which looks at the correlation of the anatomy and the function of tumours i.e. Positron Emission Tomography-Computed Tomography (PET-CT) have impacted on the improved diagnostic accuracy and treatment in oncology. Clinical data have demonstrated that the information provided by PET/CT often changes patient management. This review addresses the value of PET-CT as a surrogate molecular marker in tumours and to discuss some issues in adopting PET/CT in routine daily practice as supported by the numbers of literature reviews of its application in oncology since it was first commercialized in 2001. The description of the technology used in multimodality imaging has gained encouraging interest among physicians, policy makers and insurance companies on the importance of the PET-CT, for which roles are not limited to the staging, disease prognostication and treatment monitoring with potential impact on treatment cost and justification of radiation safety for the patient. PET/CT is a useful tool in cancer investigation as evidenced by its role as a surrogate marker in underpinning the cellular reprogramming of different pathological entities. Universiti Putra Malaysia Press 2015 Article PeerReviewed application/pdf en http://psasir.upm.edu.my/id/eprint/40625/1/Applications%20of%2018%28F%29%20FDG%20PETCT%20in%20oncology.pdf Ahmad Saad, Fathinul Fikri and Nordin, Abdul Jalil and Cheah, Yoke Kqueen and Ahmad Saad, F. N. (2015) Applications of 18(F) FDG PET/CT in oncology. Pertanika Journal of Science & Technology, 23 (1). pp. 1-12. ISSN 0128-7680; ESSN: 2231-8526 http://www.pertanika.upm.edu.my/Pertanika%20PAPERS/JST%20Vol.%2023%20%281%29%20Jan.%202015/%281%29%20JST-0431-2012%20Revised.pdf
institution Universiti Putra Malaysia
building UPM Library
collection Institutional Repository
continent Asia
country Malaysia
content_provider Universiti Putra Malaysia
content_source UPM Institutional Repository
url_provider http://psasir.upm.edu.my/
language English
description The escalating costs of conventional diagnostic technology in oncology have yet to obviate futile surgery intervention and the spiralling treatment cost. The evolution in engineering technology which looks at the correlation of the anatomy and the function of tumours i.e. Positron Emission Tomography-Computed Tomography (PET-CT) have impacted on the improved diagnostic accuracy and treatment in oncology. Clinical data have demonstrated that the information provided by PET/CT often changes patient management. This review addresses the value of PET-CT as a surrogate molecular marker in tumours and to discuss some issues in adopting PET/CT in routine daily practice as supported by the numbers of literature reviews of its application in oncology since it was first commercialized in 2001. The description of the technology used in multimodality imaging has gained encouraging interest among physicians, policy makers and insurance companies on the importance of the PET-CT, for which roles are not limited to the staging, disease prognostication and treatment monitoring with potential impact on treatment cost and justification of radiation safety for the patient. PET/CT is a useful tool in cancer investigation as evidenced by its role as a surrogate marker in underpinning the cellular reprogramming of different pathological entities.
format Article
author Ahmad Saad, Fathinul Fikri
Nordin, Abdul Jalil
Cheah, Yoke Kqueen
Ahmad Saad, F. N.
spellingShingle Ahmad Saad, Fathinul Fikri
Nordin, Abdul Jalil
Cheah, Yoke Kqueen
Ahmad Saad, F. N.
Applications of 18(F) FDG PET/CT in oncology
author_facet Ahmad Saad, Fathinul Fikri
Nordin, Abdul Jalil
Cheah, Yoke Kqueen
Ahmad Saad, F. N.
author_sort Ahmad Saad, Fathinul Fikri
title Applications of 18(F) FDG PET/CT in oncology
title_short Applications of 18(F) FDG PET/CT in oncology
title_full Applications of 18(F) FDG PET/CT in oncology
title_fullStr Applications of 18(F) FDG PET/CT in oncology
title_full_unstemmed Applications of 18(F) FDG PET/CT in oncology
title_sort applications of 18(f) fdg pet/ct in oncology
publisher Universiti Putra Malaysia Press
publishDate 2015
url http://psasir.upm.edu.my/id/eprint/40625/1/Applications%20of%2018%28F%29%20FDG%20PETCT%20in%20oncology.pdf
http://psasir.upm.edu.my/id/eprint/40625/
http://www.pertanika.upm.edu.my/Pertanika%20PAPERS/JST%20Vol.%2023%20%281%29%20Jan.%202015/%281%29%20JST-0431-2012%20Revised.pdf
_version_ 1643832770321973248
score 13.211869

Similar Items